Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Compassionate Use of Ibalizumab for the Treatment of HIV Infection

NCT02028819 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT02028819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02028819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Compassionate Use of Ibalizumab for the Treatment of HIV Infection
Lead sponsor
University of Colorado, Denver
Phase
Expanded access
Overall status
No longer available
Start date
January 31, 2012
Completion date
February 28, 2014
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus (hiv)